Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Dec 06, 2021 12:25pm
123 Views
Post# 34202525

RE:RE:RE:RE:RE:RE:Euphrates finished at 88 PMX and 106 "SHAM" in the 194 group

RE:RE:RE:RE:RE:RE:Euphrates finished at 88 PMX and 106 "SHAM" in the 194 group
Domino55 wrote: In the Out of Bounds category we also have EDTXF. The home ticker symbol of the Confirmatory P3 PMX FDA trial. The one that the CMO was tripping over in explaining how well it is going. With multiple shareholder presentations resulting in $100-$300 EDTXF trading days this is not to be discussed under any circumstances.





I think a few of us in the group, raised the point that of all the US trading in the month of November, about  60-70% of it was short.  So maybe Seto didn't exactly wow them in Oct/Nov.  BTW where's Walden? 

Interesting that although not huge by any means, the short postion on Spectral overall, as at Nov 30th (just reported)  is the highest  it has been going back 4+ years.

Odd given how well things are going overall.

People will say the short position is relatively small by other stock standards (which is true) , however for a thinly traded stock, at the margin shorting can have a significant impact on the share price in the short term. 

I have a hunch that as the tax loss selling season winds down, this short position will begin to dissapate.

No doubt a ramped up investor dog& pony show, including lighting a fire under the butt of the well paid fellow in the red/white and blue toque, will turn those frowns, upside down.

MM





<< Previous
Bullboard Posts
Next >>